Breaking News:


Add to Favorites Subscribe Share
Press "esc" to clear
Go to Advanced Search

Showing results

110 of 241
  • Embargo expired:
    11-Feb-2019 3:00 PM EST

Article ID: 707682

Sophisticated Blood Analysis Provides New Clues About Ebola, Treatment Avenues

Pacific Northwest National Laboratory

A detailed analysis of blood samples from Ebola patients is providing clues about the progression of the effects of the virus in patients and potential treatment pathways. The findings point to a critical role for a molecular pathway that relies on the common nutrient choline, as well as the importance of cellular bodies known as microvesicles.

6-Feb-2019 5:15 PM EST

Article ID: 707067

NIAID-Sponsored Clinical Trial of Ebola Vaccines Begins at Cincinnati Children's

Cincinnati Children's Hospital Medical Center

A Phase 1 clinical trial of investigational vaccines intended to protect against Zaire ebolavirus (Ebola) has begun in the United States at Cincinnati Children’s Hospital Medical Center. The study is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID).

28-Jan-2019 9:05 AM EST

Article ID: 706582

Another Piece of Ebola Virus Puzzle Identified

Texas Biomedical Research Institute

A team of researchers have discovered the interaction between an Ebola virus protein and a protein in human cells that may be an important key to unlocking the pathway of replication of the killer disease in human hosts. Scientists at Texas Biomedical Research Institute were part of a nationwide collaborative with scientists at Gladstone Institutes, UC San Francisco and Georgia State University for a study recently published in the journal Cell.

17-Jan-2019 10:00 AM EST

Article ID: 705407

Ebola-Fighting Protein Discovered in Human Cells

Northwestern University

Ebola virus (green) infects human cells much more easily when you remove the protective RBBP6 protein (compare left to right). Researchers have discovered a human protein that helps fight the Ebola virus and could one day lead to an effective therapy against the deadly disease, according to a new study from Northwestern University, Georgia State University, University of California, San Francisco (UCSF) and the Gladstone Institutes published today, Dec.

13-Dec-2018 11:05 AM EST

Article ID: 702339

Texas Biomed Scientists Researching Ebola-Malaria Connection

Texas Biomedical Research Institute

Texas Biomed researchers – in collaboration with the University of Iowa – are trying to find out how malarial infections impact people exposed to Ebola virus. Both diseases are endemic in that region.

17-Oct-2018 11:00 AM EDT
  • Embargo expired:
    10-Oct-2018 10:00 AM EDT

Article ID: 701959

Synthetic DNA Vaccine Against Ebola Virus Shows Potent and Long-term Efficacy in Preclinical Studies

Wistar Institute

A novel synthetic DNA vaccine developed based on technology pioneered by Wistar scientists offers complete protection from Zaire Ebolavirus (EBOV) infection in promising preclinical research.

10-Oct-2018 9:10 AM EDT
  • Embargo expired:
    2-Oct-2018 5:00 AM EDT

Article ID: 701256

Text Messages Quickly Track Health Care Use During Ebola Outbreak

New York University

A new study from the NYU College of Global Public Health and NYU Tandon School of Engineering, published in Nature Digital Medicine, used text message surveys to determine in real time how people used maternal health services during a recent Ebola outbreak and measured a drop in hospital-based births during the outbreak.

27-Sep-2018 1:05 PM EDT

Article ID: 700447

Rare Antibodies Show Scientists How to Neutralize the Many Types of Ebola

Scripps Research Institute

Two new studies by scientists at Scripps Research are bringing Ebola virus’s weaknesses into the spotlight, showing for the first time exactly how human and mouse antibodies can bind to the virus and stop infection—not only for Ebola virus, but for other closely related pathogens as well.

12-Sep-2018 4:45 PM EDT

Showing results

110 of 241

Chat now!